🚨 IZA-BREN SHOWS ADVANTAGE IN LUNG CANCER TRIAL Researchers said iza-bren showed a significant advantage over platinum-based chemotherapy. The phase 3 randomised, double-blind trial involved 432 patients with advanced lung cancer at 73 hospitals in China. Source: South China Morning Post #lungcancer #phase3trial
